Site map :: > Version française
TSX: 0.105   2008-08-26 15:49 EST
CAN $. Delayed Quotes.
You are here : Home > Investors
 

Investors

Company Profile

Victhom discovers, develops and manufactures bionic devices involved in the treatment of a variety of physical and physiological dysfunctions. Victhom’s Neurobionix business unit focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom’s Biotronix business unit develops biomechatronic products to support or replace peripheral limbs in what is known as orthotics and prosthetics markets.

Latest News

August 19, 2008 Victhom's Neurobionix business unit achieves ISO 13485:2003 certification
August 12, 2008 Victhom discloses second quarter 2008 financial results
July 8, 2008 A first quebec patient implanted with Victhom Nerostep™ at Hôpital de l’Enfant-Jésus of CHA
June 10, 2008 Victhom announced plan to commercialize its first neuromodulation product, the Neurostep™, in 2009
May 12, 2008 Victhom discloses first quarter 2008 financial results

View All News



Legal disclaimer
Victhom :: human bionics